Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 2Sanofi
02 4Dr. Reddy's Laboratories
03 1Polfa Tarchomin
04 2NanoAlvand
05 4Supriya Lifescience
06 2Naprod Life Sciences
07 1Ever Pharma
08 8Accord Healthcare Pty. Ltd.
09 12Accord healthcare
10 2Accure Labs
11 2Actavis Inc
12 1Activo Health
13 1Adamed Pharma
14 2Apotex Inc
15 1Aurobindo Pharma Limited
16 2BAXTER HEALTHCARE PTY LTD
17 1Baxter Healthcare Corporation
18 1Biem Ilac San. ve Tic. A.S
19 1Centocor
20 1CinnaGen Co
21 1Cipla Medpro South Africa
22 3Curanto Pharma
23 1DR REDDY'S LABORATORIES LTD
24 1Dr Reddy's Laboratories (Pty) Ltd
25 2EUGIA PHARMA (AUSTRALIA) PTY LTD
26 1Eurolab
27 2Flagship Biotech International Pvt. Ltd
28 2Fresenius Kabi USA
29 2GetWell Pharmaceutical
30 1HETERO LABS LTD VI
31 1Hansoh Pharma
32 1Hetero Drugs
33 3Hospira, Inc.
34 4InterPharma
35 1JUNO PHARMACEUTICALS CORP.
36 6Janssen-Cilag
37 2Jodas Expoim Pvt. Ltd
38 2Johnson & Johnson Innovative Medicine
39 4Juno Pharmaceuticals Pty Ltd
40 1Kiara Health
41 1MARCAN PHARMACEUTICALS INC
42 1MSN Laboratories
43 2Maia Pharmaceuticals
44 1Meitheal Pharmaceuticals
45 1NORVIUM BIOSCIENCE
46 1Nishchay Pharmaceuticals Pvt. Ltd.
47 1Panacea Biotec Limited
48 4Pfizer Consumer Healthcare
49 1Pfizer Inc
50 2Pharmacore Inc
51 2Pharmascience Inc.
52 1Qilu Pharmaceutical
53 1RELIANCE LIFE SCI
54 1SEACROSS PHARMACEUTICALS
55 1Sakar Healthcare
56 2Samyang Biopharmaceuticals
57 7Sandoz B2B
58 1ScinoPharm Taiwan Ltd
59 1Shilpa Medicare
60 2Spirig Healthcare
61 1Sun Pharmaceutical Industries Limited
62 1Takeda Pharmaceutical
63 2Taro Pharmaceutical Industries
64 2Tecnimede
65 4Teva Pharmaceutical Industries
66 2TherDose Pharma
67 1Vinkem Labs Ltd
68 1Zydus Pharmaceuticals
01 1Bortezomid 3,5Mg 1 Unit Parenteral Use
02 8Dry Sub
03 1FREEZE-DRIED POWDER
04 2INF
05 12INJ
06 2INJECTABLE; INJECTION
07 20INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
08 2INJECTION
09 3Inj L?s
10 1Inj Solution
11 1Injectable
12 10Injection
13 1LYOPHILIZED INJECTION
14 2Lyo.Inj
15 2Lyophilised Injection
16 3Lyophilized Injection
17 1Lyophilized Powder for IV/SC Injectable Solution
18 4Lyophilized Powder for Injection
19 3POI
20 12POWDER FOR SOLUTION
21 2POWDER FOR SOLUTION FOR INJECTION
22 2POWDER;INTRAVENOUS
23 2POWDER;INTRAVENOUS, SUBCUTANEOUS
24 2PULVER TILL INJEKTIONSVÄTSKA, LÖSNING
25 2Powder for Injectable Solution
26 1Powder for Solution for Injection
27 1Powder for injection fluid, resolution
28 4SOLUTION;INTRAVENOUS
29 1SOLUTION;INTRAVENOUS, SUBCUTANEOUS
30 1Solution for Injection
31 2Vial
32 29Blank
01 10DISCN
02 1Dossier Available
03 24Generic
04 1Lead Market Dossiers- Approved in both US & EU
05 1Lead Market Dossiers- Filed
06 2Originator
07 12Prescription
08 19RX
09 70Blank
01 1ACT BORTEZOMIB
02 3Alvocade
03 31BORTEZOMIB
04 2BORTEZOMIB EUGIA
05 5BORTEZOMIB FOR INJECTION
06 1BORTEZOMIB FOR INJECTION SDZ
07 2BOTETHER
08 1BOTIGEN 3,5
09 1Bertred 3,5
10 1Biemib
11 2Bortezom
12 10Bortezomib Accord
13 2Bortezomib Accord liquid
14 2Bortezomib Baxter
15 4Bortezomib Ever Pharma
16 4Bortezomib Juno
17 4Bortezomib Sandoz
18 2Bortezomib Zentiva
19 2Bortezomib liquid Spirig HC
20 1Bortiv
21 1Bortrac 3,5 mg
22 4DBL Bortezomib
23 1Miblex
24 2NEOMIB
25 1Norzib 2
26 1Onbort
27 1PMS-BORTEZOMIB
28 2PROTEZOMIB
29 2TARO-BORTEZOMIB
30 1VALOMA 3,5
31 4VELCADE
32 1VELZOMY
33 1Valoma 1
34 1Valoma 2,5
35 1Valtib
36 1Valtib 1,0 mg
37 1Valtib 2,5 Solution for Injection
38 1Valtib 3,5 Solution for Injection
39 1Velbor IV
40 5Velcade
41 1Velcade 1 mg
42 1bortezomib Accord
43 1bortezomib Sandoz
44 23Blank
01 28Australia
02 1Austria
03 12Canada
04 22India
05 3Iran
06 1Italy
07 1Norway
08 2Poland
09 2Portugal
10 17South Africa
11 2South Korea
12 4Sweden
13 12Switzerland
14 1Turkey
15 31USA
16 1United Kingdom
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Bortezomib Zentiva
Dosage Form : Dry Sub
Dosage Strength : 1mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-07-26
Application Number : 202963
Regulatory Info : RX
Registration Country : USA
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Available
Registration Country : Poland
Brand Name :
Dosage Form : Powder for Solution for Injection
Dosage Strength : 3.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Available
Registration Country : Poland
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Alvocade
Dosage Form : Vial
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilized Powder for Injection
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 2MG/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info :
Registration Country : Austria
Brand Name :
Dosage Form : Solution for Injection
Dosage Strength : 2.5MG/1ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Austria
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Bortezomib Zentiva
Dosage Form : Dry Sub
Dosage Strength : 3.5mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2019-10-04
Application Number : 206927
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in both US & EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in both US & EU
Registration Country : India
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Alvocade
Dosage Form : Vial
Dosage Strength : 3.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilized Powder for Injection
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilized Powder for Injection
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilized Powder for Injection
Dosage Strength : 3.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 3.5MG/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-07-26
Application Number : 204405
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date :
Application Number : 208645
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 3.5MG/1.4ML
Packaging :
Approval Date :
Application Number : 208645
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-05-02
Application Number : 205533
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2017-11-06
Application Number : 205004
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-07-26
Application Number : 208460
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 1MG/VIAL
Packaging :
Approval Date : 2022-05-02
Application Number : 209191
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 2.5MG/VIAL
Packaging :
Approval Date : 2022-05-02
Application Number : 209191
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-07-26
Application Number : 209622
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-05-02
Application Number : 208392
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-07-26
Application Number : 203654
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VELCADE
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2003-05-13
Application Number : 21602
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-05-02
Application Number : 205857
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BORTEZOMIB
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 3.5MG/VIAL
Packaging :
Approval Date : 2022-10-31
Application Number : 205160
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
